BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 10, 2007
View Archived Issues
Sirion Series B Raises $45M For Phase III Ophthalmic Bid
Ophthalmics-targeted Sirion Therapeutics Inc. pulled down $45 million in a Series B financing to boost a pipeline led by ST-601, the Phase III emulsion acquired last year for inflamed eyes. (BioWorld Today)
Read More
Senate Schedules Stem Cell Debate And Vote For Today
Read More
Alteon Raising $25M Privately, Expanding Rights To ALT-2074
Read More
Melior Grants Pfizer Access To Multiplexed In Vivo Platform
Read More
EPA Awards $111M In BioPharma Contracts
Read More
Appointments And Advancements
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Financings Roundup
Read More